Nvidia shares have careened between competing narratives this week, as a US decision to ease chip export restrictions to the United Arab Emirates and the company’s swift denial of a product-delay rumor squared off against lingering questions over China access and the sustainability of hyperscaler investment. The result has been a stock that, while broadly trending higher, remains acutely sensitive to the next headline.
On Monday, the stock fell 2.87% to €179.30, retreating from the prior Friday’s close of €184.60. The sell-off came even as the Trump administration opened a new geographic front for Nvidia’s advanced chips by loosening export rules for the UAE. The move could allow G42 and Microsoft to purchase cutting-edge AI processors for data centers in the Emirates—though no firm supply contract is in place, making the development a policy signal rather than a concrete revenue catalyst. Later in the week, the stock rebounded to €181.80 after Nvidia quashed a report that its next-generation Kyber NVL144 platform would slip to 2028. The denial propelled the shares up more than 1%, yet the bounce still left the stock 1.52% below its Friday close. Over the trailing week, the equity has gained 6.33% (versus 4.87% earlier in the week), and the year-to-date advance stands at 12.85%.
The contrasting moves underscore the two forces driving Nvidia’s near-term trajectory: constructive product and policy news on one side, and unresolved structural risks on the other. On the positive front, the UAE opening adds a fresh source of demand at a time when hyperscalers are pushing capital expenditure higher. Goldman Sachs expects industry-wide AI investment to climb from $650 billion in 2026 to $1 trillion in 2027, and Nvidia chief Jensen Huang has pegged combined demand for the Blackwell and Rubin platforms at over $1 trillion by 2027. The company’s Rubin architecture remains on track for a second-half 2026 launch, followed by Kyber NVL144—a rack-scale system integrating multiple GPUs for AI training and inference. The management’s insistence that the Kyber timeline is intact gives bulls confidence that the current valuation does not reflect the growth ahead.
Yet the bear case has not lost its grip. China exposure remains structurally impaired: licenses for H20 chips approved in August 2025 generated only $60 million in revenue, a fraction of Nvidia’s historical China sales. The licensing framework is provisional and legally vulnerable—the US government reportedly expects a 15% or higher commission on such license revenue, but no formal rule exists, leaving the arrangement open to challenge or reversal. Any tightening of controls or further delays in approvals would slice deeper into what was once a major profit center.
Should investors sell immediately? Or is it worth buying Nvidia?
The Kyber delay denial, while calming markets, does not eliminate execution risk. The original report came from a credible source, and until actual shipments begin, the product roadmap will remain a source of unease. With an annualized 30-day volatility of around 37%, the shares are primed for outsized moves on any fresh rumor or earnings commentary.
Technically, the stock sits in a zone that mirrors the debate. The current price of €181.80 is just 0.19% above its 50-day moving average of €181.46 (the primary article cited a similar 50-day of €181.41), while the 200-day average at roughly €164.90 is about 10.25% below. The RSI of 55.1 (vs. 52.2 earlier in the week) points to neutral territory, leaving room for movement in either direction. The 52-week high of €202.50, set in May, is 10.22% above the current level, while the 52-week low of €140.62 provides a floor some 27.5% beneath.
Analyst consensus remains firmly bullish, with a price target of about €264—representing upside of roughly 45-48% from the current quote. That target implies that Wall Street sees the current 21.7 times forward earnings, roughly in line with the S&P 500, as too cheap given Nvidia’s revenue growth and product-cycle momentum. The bull case argues that as hyperscaler capex continues to rise, the valuation gap will close. The bear case counters that a slowdown in capital-expenditure growth, combined with China headwinds and possible roadmap hiccups, could drive the stock toward the 200-day average—a signal that the buying-on-dips narrative has shifted to a wait-and-see stance.
The next concrete test arrives with Nvidia’s fiscal second-quarter earnings, expected in late August 2026. Management’s commentary on Blackwell shipments, Rubin progress, and Kyber NVL144 details will either validate the current constructive mood or reignite doubts. Until then, the stock is likely to remain a prisoner of the latest headline—weighing an expanded geographic footprint and a defended roadmap against the unresolved questions of China and execution.
Ad
Nvidia Stock: Buy or Sell?! New Nvidia Analysis from July 13 delivers the answer:
The latest Nvidia figures speak for themselves: Urgent action needed for Nvidia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 13.
Nvidia: Buy or sell? Read more here...
